SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is seeing massive upward momentum driven by intense short interest and mounting anticipation for an imminent phase 3 trial milestone, leading the community to discuss a potential gamma squeeze and long-term buyout scenarios. Investors are actively tracking high borrow fees and record engagement, with many pointing to the trial's unusually long duration as evidence of strong clinical outcomes.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust is experiencing intense selling pressure as technical support levels are tested and investors grapple with broader macro uncertainty and a strengthening US dollar. The community is deeply divided, with some investors panic-selling into the decline while long-term bulls argue that the current price action is an opportunity to accumulate physical assets amidst structural supply deficits.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is facing increased volatility and bearish sentiment following reports of a raid on its Taiwan offices by authorities investigating the illicit diversion of AI hardware. While some investors interpret the event as a routine compliance follow-up to ongoing export-control probes, the community remains deeply divided, with many debating whether this represents a systemic management failure or a target-of-opportunity for short-sellers to induce panic selling.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack In The Box is experiencing significant market attention driven by a combination of heavy short interest and speculation regarding a potential short squeeze. Community discussion is split between traders targeting the low float for explosive upside and skeptics focused on the company's debt levels and operational challenges.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors weigh a wave of strategic AI partnerships and defense-sector contract wins against persistent volatility and technical selling pressure. While the community is actively debating the company's long-term potential as an AI-native network infrastructure player, many remain focused on identifying a potential bottom ahead of upcoming earnings.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is currently trending as investors weigh significant operational updates, including successful production and offtake agreements, against short-selling activity and regulatory challenges. The community is actively debating the stock's long-term valuation in light of these volatile price swings and the upcoming production capacity expansion.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

ABVX is seeing high volatility as investors debate the impact of newly disclosed malignancy cases in the Phase 3 clinical trial against the drug's best-in-class efficacy data. The community is sharply divided, with bulls viewing the sell-off as a manipulative overreaction to noise and a prime buying opportunity, while others express concerns over potential regulatory hurdles like black box warnings.

Tidal Trust II - YieldMax Semiconductor Portfolio Option Income ETF

YieldMax Semiconductor Portfolio Option Income ETF

CHPY is trending as investors favor its unique strategy of holding underlying semiconductor stocks alongside a call spread overlay, which helps mitigate the significant NAV erosion often seen in synthetic-only option income funds. The community is actively debating its role in generating consistent weekly cash flow, with many highlighting its resilience during market fluctuations compared to other YieldMax products.

Zillow Group, Inc. engages in the provision of real estate and home-related information marketplaces on mobile and the web. The company was founded by Richard N. Barton and Lloyd D. Frink in December 2004 and is headquartered in Seattle, WA.

Zillow Group Inc - Ordinary Shares - Class C

Zillow Group Inc Class C

Zillow is seeing increased volatility as investors weigh the potential for antitrust litigation and regulatory pressure against the company's efforts to scale its 'Super App' ecosystem and AI integration. Market participants are actively debating whether these legal headwinds present a buying opportunity for a long-term turnaround or if competitive threats from broader tech players like Alphabet could disrupt the company's core lead-generation business.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors debate the impact of newly announced price hikes on MacBooks and iPads, which the company attributes to severe memory chip supply shortages. The community is actively discussing whether Apple can maintain its pricing power and margins despite these rising input costs, while some speculate on the company's potential pivot toward alternative suppliers to secure necessary components.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference

Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced that the Company will present at the following investor conference in New York: 2026 Jefferies...

Arcturus Therapeutics (ARCT) Reports Q1 Loss, Lags Revenue Estimates

Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of +16.91% and -73.79%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress

Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today...

Arcturus Therapeutics (ARCT) Projected to Post Earnings on Thursday

Arcturus Therapeutics (NASDAQ:ARCT) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...

Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates

Illumina (ILMN) delivered earnings and revenue surprises of +9.70% and +1.15%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Arcturus Therapeutics (NASDAQ:ARCT) Shares Cross Below 200 Day Moving Average   - Time to Sell?

Arcturus Therapeutics (NASDAQ:ARCT) Stock Passes Below 200-Day Moving Average - What's Next...

Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026

Diversify Advisory Services LLC Sells 115,500 Shares of Arcturus Therapeutics Holdings Inc. $ARCT

Diversify Advisory Services LLC reduced its stake in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT - Free Report) by 88.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,00...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Consensus Rating of "Moderate Buy" from Brokerages

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the thirteen brokerages that are currently covering the firm...

Arcturus Therapeutics (NASDAQ:ARCT) Share Price Passes Below Two Hundred Day Moving Average - What's Next?

Arcturus Therapeutics (NASDAQ:ARCT) Stock Passes Below Two Hundred Day Moving Average - What's Next...

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics Stock Plunges Over 58% Today: What’s Causing The Sell-Off?

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$6.82
Prev Close	$6.88
Open	$6.88
Dividend Yield	0.00%
50-Day Moving Average	$7.83
Beta	1.77
Avg. Volume	461,268.70
PE Ratio	-2.44

52-Week High	$24.17
52-Week Low	$5.85
Market Capitalization	$195.55M
EPS (Annual)	-$2.40
Price to Book	1.02
Revenue Per Employee	$605,594.59

Feed

News

Sentiment

Earnings

Fundamentals

Info

ARCTArcturus Therapeutics Holdings Inc

Latest ARCT News